StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$5.27+0.19 (+3.74%)

Close on Nov 20, 2026Market cap $410.77MP/E –Yield –

CorMedix gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

CorMedix's gross profit for the twelve months ending Jun 30, 2026 was $382.64M, up 229.4% year over year. For fiscal 2025 it was $275.75M, up 584.5% from the year before. The highest annual figure on record is $275.75M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$275.75M+584.5%
FY2024Dec 31, 2024$40.28M+65214.4%
FY2022Dec 31, 2022$61.67K+46.8%
FY2021Dec 31, 2021$42.00K+22.1%
FY2020Dec 31, 2020$34.39K–
FY2019Dec 31, 2019-$89.97K-372.5%
FY2018Dec 31, 2018$33.01K-84.6%
FY2017Dec 31, 2017$214.36K–
FY2016Dec 31, 2016-$142.57K–
FY2015Dec 31, 2015-$108.59K–
FY2014Dec 31, 2014-$256.53K–
FY2013Dec 31, 2013-$199.60K–
FY2012Dec 31, 2012$0–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$77.13M+103.6%
Q1 FY2026Mar 31, 2026$105.12M+180.4%
Q4 FY2025Dec 31, 2025$107.31M+257.3%
Q3 FY2025Sep 30, 2025$93.08M+764.3%
Q2 FY2025Jun 30, 2025$37.87M+12683.2%
Q1 FY2025Mar 31, 2025$37.49M–
Q4 FY2024Dec 31, 2024$30.03M+102421.6%
Q3 FY2024Sep 30, 2024$10.77M+201274.7%
Q2 FY2024Jun 30, 2024$296.28K+1316.2%
Q1 FY2024Mar 31, 2024-$818.54K-13498.9%
Q4 FY2022Dec 31, 2022$29.30K+249.2%
Q3 FY2022Sep 30, 2022$5.35K-58.6%
Q2 FY2022Jun 30, 2022$20.92K–
Q1 FY2022Mar 31, 2022$6.11K-77.3%
Q4 FY2021Dec 31, 2021$8.39K–
Q3 FY2021Sep 30, 2021$12.92K-1.4%
Q2 FY2021Jun 30, 2021-$6.24K–
Q1 FY2021Mar 31, 2021$26.92K+5.4%
Q4 FY2020Dec 31, 2020-$1.52K–
Q3 FY2020Sep 30, 2020$13.11K–
Q2 FY2020Jun 30, 2020-$2.74K-119.4%
Q1 FY2020Mar 31, 2020$25.54K–
Q4 FY2019Dec 31, 2019-$21.35K-584.2%
Q3 FY2019Sep 30, 2019-$19.50K-132.5%
Q2 FY2019Jun 30, 2019$14.14K–
Q1 FY2019Mar 31, 2019-$63.26K–
Q4 FY2018Dec 31, 2018$4.41K-97.2%
Q3 FY2018Sep 30, 2018$60.08K–
Q2 FY2018Jun 30, 2018-$26.11K-122.1%
Q1 FY2018Mar 31, 2018-$5.37K–
Q4 FY2017Dec 31, 2017$155.84K+432783.3%
Q3 FY2017Sep 30, 2017-$5.58K-1154.3%
Q2 FY2017Jun 30, 2017$118.12K–
Q1 FY2017Mar 31, 2017-$54.01K–
Q4 FY2016Dec 31, 2016$36–
Q3 FY2016Sep 30, 2016$529–

More CorMedix figures

See a number that looks wrong?